美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

赛生药业

11.15

0.0000

成交量：- -

成交额：- -

市值：5.82亿

市盈率：13.60

高：11.15

开：11.15

低：11.15

收：11.15

52周最高：11.43

52周最低：8.55

股本：5,219.20万

流通股本：4,527.09万

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):0.8200

净资产收益率：--

总资产收益率：--

市净率：2.33

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

赛生药业

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.sciclone.com

邮编：

- -

电话：

- -

传真：

- -

简介：

赛生药业公司组建于1990年，是一家加州公司，并于2003年在特拉华州重新合并。赛生制药是一家创收，盈利，面向中国的美国专业制药公司，拥有大量的商业业务和为肿瘤，传染病，心血管，泌尿系统，呼吸系统和中枢神经系统紊乱的疗法产品。该公司致力于通过其强大的销售和营销工作和发展盈利能力来加快国际销售增长。该公司的业务及企业策略主要集中在中国，并通过其多年的营销经验，在那里已经建立了良好的声誉和强大的品牌，其主导产品是ZADAXIN（日达仙）。该公司认为其优势地位可以使之从中国的医药市场扩张中受益。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/SCLN/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"SCLN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCLN\",,,,,undefined,":{"symbol":"SCLN","market":"US","secType":"STK","nameCN":"赛生药业","latestPrice":11.15,"timestamp":1515186000000,"preClose":11.15,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":45270936,"shares":52192000,"eps":0.82,"marketStatus":"交易中","change":0,"latestTime":"03-10 13:30:28 EDT","open":11.15,"high":11.15,"low":11.15,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.82,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1773172800000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":700808400000,"exchange":"NASDAQ","adjPreClose":11.15,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCLN\",,,,,undefined,":{"symbol":"SCLN","floatShares":45270936,"roa":"--","roe":"--","lyrEps":0,"shares":52192000,"dividePrice":0,"high":11.15,"amplitude":0,"preClose":11.15,"low":11.15,"week52Low":8.55,"pbRate":"2.33","week52High":11.425,"institutionHeld":0.4567,"latestPrice":11.15,"eps":0.82,"divideRate":0,"volume":0,"delay":0,"ttmEps":0.82,"open":11.15,"prevYearClose":11.15},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SCLN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2017-08-09","symbol":"SCLN","fiscalQuarterEnding":"2017/06","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1502251200000,"reportTimeType":"post","actualEps":0.26},{"market":"US","date":"2017-05-10","symbol":"SCLN","fiscalQuarterEnding":"2017/03","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1494388800000,"reportTimeType":"post","actualEps":0.29},{"market":"US","date":"2017-03-06","symbol":"SCLN","fiscalQuarterEnding":"2016/12","expectedEps":null,"name":null,"time":"盘前","type":"earning","dateTimestamp":1488776400000,"reportTimeType":"pre","actualEps":0.17},{"market":"US","date":"2016-11-09","symbol":"SCLN","fiscalQuarterEnding":"2016/09","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1478667600000,"reportTimeType":"post","actualEps":0.19},{"market":"US","date":"2016-08-09","symbol":"SCLN","fiscalQuarterEnding":"2016/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1470715200000,"reportTimeType":"","actualEps":0.18}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SCLN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SCLN\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.sciclone.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0118},{"period":"1month","weight":-0.0179},{"period":"3month","weight":-0.007},{"period":"6month","weight":0.04},{"period":"1year","weight":0.1777},{"period":"ytd","weight":-0.0054}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"赛生药业公司组建于1990年，是一家加州公司，并于2003年在特拉华州重新合并。赛生制药是一家创收，盈利，面向中国的美国专业制药公司，拥有大量的商业业务和为肿瘤，传染病，心血管，泌尿系统，呼吸系统和中枢神经系统紊乱的疗法产品。该公司致力于通过其强大的销售和营销工作和发展盈利能力来加快国际销售增长。该公司的业务及企业策略主要集中在中国，并通过其多年的营销经验，在那里已经建立了良好的声誉和强大的品牌，其主导产品是ZADAXIN（日达仙）。该公司认为其优势地位可以使之从中国的医药市场扩张中受益。","exchange":"NASDAQ","name":"赛生药业","nameEN":"SciClone Pharmaceuticals"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"SCLN\",market:\"US\",,,undefined,":null}}